Literature DB >> 3328720

Effect of the enteroinsular axis on both the A- and B-cell response to arginine after oral glucose in man.

I Shimizu1, M Hirota, C Ohboshi, A Mizuno, K Shima.   

Abstract

Studies were made on the effect of the enteroinsular axis on amino acid-induced insulin and glucagon secretion during hyperglycaemia in man. The responses of plasma immunoreactive insulin, C-peptide, and immunoreactive glucagon to arginine infusion were investigated in nine healthy subjects after induction of hyperglycaemia by an oral glucose load and by intravenous glucose infusion to produce similar glucose concentrations in the arterialised blood. The plasma immunoreactive insulin and C-peptide levels increased to higher levels after an oral glucose load than after an intravenous infusion of glucose. The incremental areas under the immunoreactive insulin and C-peptide curves during arginine infusion were significantly greater (p less than 0.01) after oral than after intravenous glucose administration. The plasma immunoreactive glucagon level was suppressed equally after oral and intravenous glucose loads. However, during subsequent arginine infusion, the plasma immunoreactive glucagon level rose more in the presence of hyperglycaemia induced by oral than intravenous glucose. The incremental area under the plasma immunoreactive glucagon curve during arginine infusion was 1.6-fold greater after glucose ingestion than after intravenous glucose infusion. These results suggest that the enteroinsular axis has a stimulatory effect on the responses of pancreatic A and B cells to arginine after oral glucose administration.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3328720     DOI: 10.1007/bf00274792

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  19 in total

Review 1.  The incretin concept today.

Authors:  W Creutzfeldt
Journal:  Diabetologia       Date:  1979-02       Impact factor: 10.122

2.  Alimentary factors in the endocrine response to administration of arginine in man.

Authors:  J Dupré; J D Curtis; R W Waddell; J C Beck
Journal:  Lancet       Date:  1968-07-06       Impact factor: 79.321

3.  Role of glucose in arginine-induced insulin release in man.

Authors:  S Efendic; E Cerasi; R Luft
Journal:  Metabolism       Date:  1971-06       Impact factor: 8.694

4.  Aging and diabetes.

Authors:  R Andres
Journal:  Med Clin North Am       Date:  1971-07       Impact factor: 5.456

5.  Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.

Authors:  S Mojsov; G C Weir; J F Habener
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

6.  Enhancement of arginine-induced insulin secretion in man by prior administration of glucose.

Authors:  S R Levin; J H Karam; S Hane; G M Grodsky; P H Forsham
Journal:  Diabetes       Date:  1971-03       Impact factor: 9.461

7.  Oral glucose decreases hepatic extraction of insulin.

Authors:  O M Gibby; C N Hales
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-19

8.  Comparison of peripheral glucose uptake after oral glucose loading and a mixed meal.

Authors:  R A Jackson; P M Blix; J A Matthews; L M Morgan; A H Rubenstein; J D Nabarro
Journal:  Metabolism       Date:  1983-07       Impact factor: 8.694

9.  Interaction of gastric inhibitory polypeptide, glucose, and arginine on insulin and glucagon secretion from the perfused rat pancreas.

Authors:  R A Pederson; J C Brown
Journal:  Endocrinology       Date:  1978-08       Impact factor: 4.736

10.  Effects of cholecystokinin, gastric inhibitory polypeptide, and secretin on insulin and glucagon secretion in rats.

Authors:  J Szecówka; P E Lins; S Efendić
Journal:  Endocrinology       Date:  1982-04       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.